Health-related Quality of Life in Patients with Inflammatory Bowel Disease 20 Years after Diagnosis: Results from the IBSEN Study

Inflammatory Bowel Diseases

Volumn 22, Issue 7, 2016, Pages 1679-1687

  Huppertz Hauss, Gert ^a   Lie Høivik, Marte ^b   Jelsness Jørgensen, Lars Petter ^c   Henriksen, Magne ^d   Høie, Ole ^e   Jahnsen, Jørgen ^f   Hoff, Geir ^a   Moum, Bjørn ^b   Bernklev, Tomm ^a  

^a TELEMARK HOSPITAL   (Norway)

^b ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^c ØSTFOLD UNIVERSITY COLLEGE   (Norway)

^d Ostfold Hospital Trust   (Norway)

^e Section for Gastroenterology   (Norway)

^f AKERSHUS UNIVERSITY HOSPITAL   (Norway)

Author keywords

Crohn's disease; health related quality of life; quality of life in IBD; ulcerative colitis

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL EXAMINATION; COHORT ANALYSIS; CONTROLLED STUDY; CROHN DISEASE; DISEASE ACTIVITY; FEMALE; FOLLOW UP; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUALITY OF LIFE; SHORT FORM 36; STRUCTURED INTERVIEW; ULCERATIVE COLITIS; BLOOD; CASE CONTROL STUDY; CHEMISTRY; COMPLICATION; DISEASE EXACERBATION; FECES; METABOLISM; MIDDLE AGED; NORWAY; QUESTIONNAIRE; RECURRENT DISEASE; SEVERITY OF ILLNESS INDEX; SEX FACTOR; TIME FACTOR; UNEMPLOYMENT; VERY ELDERLY; YOUNG ADULT;

C REACTIVE PROTEIN; CALGRANULIN;

ADULT; AGED; AGED, 80 AND OVER; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; COLITIS, ULCERATIVE; CROHN DISEASE; DISEASE PROGRESSION; FECES; FEMALE; FOLLOW-UP STUDIES; HUMANS; LEUKOCYTE L1 ANTIGEN COMPLEX; MALE; MIDDLE AGED; NORWAY; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX; SEX FACTORS; SURVEYS AND QUESTIONNAIRES; SYMPTOM FLARE UP; TIME FACTORS; UNEMPLOYMENT; YOUNG ADULT;

EID: 84976260208     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1097/MIB.0000000000000806     Document Type: Article

References (38)

1. Hoie O, Schouten LJ, Wolters FL, et al. Ulcerative colitis: no rise in mortality in a European-wide population based cohort 10 years after diagnosis. Gut. 2007;56:497-503
2. Hovde O, Kempski-Monstad I, Smastuen MC, et al. Mortality and causes of death in Crohn's disease: results from 20 years of follow-up in the IBSEN study. Gut. 2014;63:771-775
3. Lennard-Jones JE. Classification of inflammatory bowel disease. Scand J Gastroenterol Suppl. 1989;170:2-6; discussion 16-19
4. Larsen S, Bendtzen K, Nielsen OH. Extraintestinal manifestations of inflammatory bowel disease: epidemiology, diagnosis, and management. Ann Med. 2010;42:97-114
5. Moum B, Ekbom A, Vatn MH, et al. Clinical course during the 1st year after diagnosis in ulcerative colitis and Crohn's disease. Results of a large, prospective population-based study in southeastern Norway, 1990-93. Scand J Gastroenterol. 1997;32:1005-1012
6. Henriksen M, Jahnsen J, Lygren I, et al. Clinical course in Crohn's disease: results of a five-year population-based follow-up study (the IBSEN study). Scand J Gastroenterol. 2007;42:602-610
7. Henriksen M, Jahnsen J, Lygren I, et al. Ulcerative colitis and clinical course: results of a 5-year population-based follow-up study (the IBSEN study). Inflamm Bowel Dis. 2006;12:543-550
8. Solberg IC, Lygren I, Jahnsen J, et al. Clinical course during the first 10 years of ulcerative colitis: results from a population-based inception cohort (IBSEN Study). Scand J Gastroenterol. 2009;44:431-440
9. Solberg IC, Vatn MH, Hoie O, et al. Clinical course in Crohn's disease: results of a Norwegian population-based ten-year follow-up study. Clin Gastroenterol Hepatol. 2007;5:1430-1438
10. Bernklev T, Jahnsen J, Aadland E, et al. Health-related quality of life in patients with inflammatory bowel disease five years after the initial diagnosis. Scand J Gastroenterol. 2004;39:365-373
11. Hoivik ML, Bernklev T, Solberg IC, et al. Patients with Crohn's disease experience reduced general health and vitality in the chronic stage: tenyear results from the IBSEN study. J Crohns Colitis. 2012;6:441-453
12. Hoivik ML, Moum B, Solberg IC, et al. Health-related quality of life in patients with ulcerative colitis after a 10-year disease course: results from the IBSEN study. Inflamm Bowel Dis. 2012;18:1540-1549
13. Nordin K, Pahlman L, Larsson K, et al. Health-related quality of life and psychological distress in a population-based sample of Swedish patients with inflammatory bowel disease. Scand J Gastroenterol. 2002;37: 450-457
14. Rubin GP, Hungin AP, Chinn DJ, et al. Quality of life in patients with established inflammatory bowel disease: a UK general practice survey. Aliment Pharmacol Ther. 2004;19:529-535
15. Graff LA, Walker JR, Lix L, et al. The relationship of inflammatory bowel disease type and activity to psychological functioning and quality of life. Clin Gastroenterol Hepatol. 2006;4:1491-1501
16. Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30: 473-483
17. Guyatt G, Mitchell A, Irvine EJ, et al. A new measure of health status for clinical trials in inflammatory bowel disease. Gastroenterology. 1989;96: 804-810
18. Harvey RF, Bradshaw JM. A simple index of Crohn's-disease activity. Lancet. 1980;1:514
19. Walmsley RS, Ayres RC, Pounder RE, et al. A simple clinical colitis activity index. Gut. 1998;43:29-32
20. Higgins PD, Schwartz M, Mapili J, et al. Patient defined dichotomous end points for remission and clinical improvement in ulcerative colitis. Gut. 2005;54:782-788
21. Burri E, Beglinger C. The use of fecal calprotectin as a biomarker in gastrointestinal disease. Expert Rev Gastroenterol Hepatol. 2014;8:197-210
22. Ware JE Jr, Gandek B. Overview of the SF-36 health survey and the International Quality of Life Assessment (IQOLA) project. J Clin Epidemiol. 1998;51:903-912
23. Loge JH, Kaasa S. Short form 36 (SF-36) health survey: normative data from the general Norwegian population. Scand J Soc Med. 1998; 26:250-258
24. Loge JH, Abrahamsen AF, Ekeberg O, et al. Reduced health-related quality of life among Hodgkin's disease survivors: a comparative study with general population norms. Ann Oncol. 1999;10:71-77
25. Bernklev T, Moum B, Moum T, et al. Quality of life in patients with inflammatory bowel disease: translation, data quality, scaling assumptions, validity, reliability and sensitivity to change of the Norwegian version of IBDQ. Scand J Gastroenterol. 2002;37:1164-1174
26. Norman GR, Sloan JA, Wyrwich KW. Interpretation of changes in healthrelated quality of life: the remarkable universality of half a standard deviation. Med Care. 2003;41:582-592
27. Cohen J. Statistical Power Analysis for the Behavioral Sciences. 2nd ed. Hillsdale, NJ: L. Erlbaum Associates; 1988
28. Sullivan GM, Feinn R. Using effect size-or why the P value is not enough. J Grad Med Educ. 2012;4:279-282
29. Huppertz-Hauss G, Hoivik ML, Langholz E, et al. Health-related quality of life in inflammatory bowel disease in a European-wide populationbased cohort 10 years after diagnosis. Inflamm Bowel Dis. 2015;21: 337-344
30. Bernklev T, Jahnsen J, Schulz T, et al. Course of disease, drug treatment and health-related quality of life in patients with inflammatory bowel disease 5 years after initial diagnosis. Eur J Gastroenterol Hepatol. 2005;17:1037-1045
31. Bernklev T, Jahnsen J, Henriksen M, et al. Relationship between sick leave, unemployment, disability, and health-related quality of life in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2006;12: 402-412
32. Canavan C, Abrams KR, Hawthorne B, et al. Long-term prognosis in Crohn's disease: factors that affect quality of life. Aliment Pharmacol Ther. 2006;23:377-385
33. Stjernman H, Tysk C, Almer S, et al. Unfavourable outcome for women in a study of health-related quality of life, social factors and work disability in Crohn's disease. Eur J Gastroenterol Hepatol. 2011;23:671-679
34. van der Have M, van der Aalst KS, Kaptein AA, et al. Determinants of health-related quality of life in Crohn's disease: a systematic review and meta-analysis. J Crohns Colitis. 2014;8:93-106
35. Palm O, Bernklev T, Moum B, et al. Non-inflammatory joint pain in patients with inflammatory bowel disease is prevalent and has a significant impact on health related quality of life. J Rheumatol. 2005;32:1755-1759
36. Hlavaty T, Persoons P, Vermeire S, et al. Evaluation of short-term responsiveness and cutoff values of inflammatory bowel disease questionnaire in Crohn's disease. Inflamm Bowel Dis. 2006;12:199-204
37. Irvine EJ. Quality of life of patients with ulcerative colitis: past, present, and future. Inflamm Bowel Dis. 2008;14:554-565
38. Lonnfors S, Vermeire S, Greco M, et al. IBD and health-related quality of life-discovering the true impact. J Crohns Colitis. 2014;8:1281-1286